 In this study, researchers investigated the prevalence of anti-beta-2 glycoprotein-i, AB2GPI, antibodies in patients with renal diseases and suspected antifospholipid syndrome, APS. They found that IgA, AB2GPI antibodies were more common than IgM and IgG isotopes in patients with renal diseases and those who tested positive for APS. Additionally, they observed that IgA, AB2GPI persisted in 22 out of 29 patients who were retested, suggesting that it may be a better marker for diagnosing APS in patients with renal diseases. This article was authored by Sabiha Anis, Ijaz Ahmed, and Rana Muzafor.